Log In
Print this Print this


  Manage Alerts
Collapse Summary General Information
Company Horizon Pharma plc
DescriptionReceptor associated protein (RAP)-based peptide targeting LRP1
Molecular Target Low-density lipoprotein-related protein 1 alpha-2-macroglobulin receptor (LRP1) (CD91)
Mechanism of Action 
Therapeutic ModalityPeptide
Latest Stage of DevelopmentPreclinical
Standard IndicationLiver cancer
Indication DetailsTreat hepatocellular carcinoma (HCC)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today